{
    "eid": "2-s2.0-85053416459",
    "title": "Drug-induced stevens-johnson syndrome and toxic epidermal necrolysis call for optimum patient stratification and theranostics via pharmacogenomics",
    "cover-date": "2018-08-31",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Genetics",
            "@code": "1311",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Genetics (clinical)",
            "@code": "2716",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "pharmacogenomics",
        "severe cutaneous adverse reactions",
        "SJS/TEN"
    ],
    "authors": [
        "Chonlaphat Sukasem",
        "Theodora Katsila",
        "Therdpong Tempark",
        "George P. Patrinos",
        "Wasun Chantratita"
    ],
    "citedby-count": 19,
    "ref-count": 119,
    "ref-list": [
        "Delayed drug hypersensitivity: Models of T-cell stimulation",
        "Pharmacogenetics of cutaneous adverse drug reactions",
        "Stevens-Johnson syndrome and toxic epidermal necrolysis in the pediatric population: A review",
        "Association study of lamotrigine-induced cutaneous adverse reactions and HLA-B?1502 in a Han Chinese population",
        "Haptens, prohaptens and prehaptens, or electrophiles and proelectrophiles",
        "Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin",
        "A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions",
        "Personalized medicine, genomics, and pharmacogenomics: A primer for nurses",
        "Granzymes at a glance",
        "Data mining FAERS to analyze molecular targets of drugs highly associated with Stevens-Johnson syndrome",
        "CYP2B6 c. 983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populations",
        "Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population",
        "Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing",
        "Association of HLA-B? 15: 13 and HLA-B?15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population",
        "Association of HLA-B?1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population",
        "Effects of a HLA-B? 15: 02 screening policy on antiepileptic drug use and severe skin reactions",
        "Genetic variants associated with phenytoin-related severe cutaneous adverse reactions",
        "Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: The impact of renal insufficiency, high plasma levels of oxypurinol and granulysin",
        "Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis",
        "Genetic predisposition of life-threatening antiepilepticinduced skin reactions",
        "Medical genetics: A marker for Stevens-Johnson syndrome",
        "Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Severe cutaneous adverse drug reactions",
        "Association between CYP2B6 polymorphisms and Nevirapine-induced SJS/TEN: A pharmacogenetics study",
        "Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS): A review of current concepts",
        "Pharmacogenomics of adverse drug reactions",
        "Recent advances of pharmacogenomics in severe cutaneous adverse reactions: Immune and nonimmune mechanisms",
        "Effectiveness of eletriptan in acute migraine: Primary care for Excedrin nonresponders",
        "Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS",
        "Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome",
        "A review of causes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children",
        "HLA-B? 58: 01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population",
        "Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel",
        "Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing",
        "Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions",
        "HLA-B?5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol",
        "Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese",
        "Immune self-reactivity triggered by drug-modified HLA-peptide repertoire",
        "Positive and negative associations of HLA class i alleles with allopurinol-induced SCARs in Koreans",
        "Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury",
        "Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects",
        "Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: Dependence on its timing and the type of drug eruption",
        "Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients",
        "Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans",
        "Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome",
        "Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions",
        "Association of HLA-A and HLA-B alleles with lamotrigine-induced cutaneous adverse drug reactions in the Thai population",
        "HLA-B?1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain",
        "Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors",
        "Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice",
        "Clinical Pharmacogenetics ImplementationConsortium guidelines forHLA-B genotype and carbamazepine dosing",
        "Clinical application of pharmacogenomics: The example ofHLA-based drug-induced toxicity",
        "Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A pooled analysis",
        "Prognosis of generalized bullous fixed drug eruption: Comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B?1502 allele in Thai population",
        "Pharmacogenetic screening of carbamazepineinduced severe cutaneous allergic reactions",
        "Global implementation of genomic medicine: We are not alone",
        "Research directions in genetic predispositions to Stevens-Johnson syndrome/toxic epidermal necrolysis",
        "Phenobarbitalinduced severe cutaneous adverse drug reactions are associated with CYP2C19?2 in Thai children",
        "HLA-A?3101 and carbamazepine-induced hypersensitivity reactions in Europeans",
        "Association of HLA-B?1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians",
        "Stevens-Johnson syndrome and toxic epidermal necrolysis: An analysis of triggers and implications for improving prevention",
        "Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical patterns, diagnostic considerations, etiology, and therapeutic management",
        "Ethical, social and legal implications of pharmacogenomics: A critical review",
        "Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis",
        "Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome",
        "HLA-B?1502 and carbamazepineinduced severe cutaneous adverse drug reactions in Vietnamese",
        "Intracellular mediators of granulysininduced cell death",
        "Genome-wide association study identifies HLA-A?3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population",
        "Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy",
        "HLA and TCR recognition of medications in severe cutaneous adverse reactions",
        "Measuring the value of pharmacogenomics evidence",
        "Drug hypersensitivity: Pharmacogenetics and clinical syndromes",
        "Delayed drug hypersensitivity reactions",
        "Interaction of small molecules with specific immune receptors: The p-i concept and its consequences",
        "Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity",
        "Perspectives from South and East Asia on clinical and research ethics: A literature review",
        "Economic evaluation of HLA-B? 15: 02 screening for carbamazepine-induced severe adverse drug reactions in Thailand",
        "Ethical and legal implications of pharmacogenomics",
        "Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis",
        "Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)",
        "Pathogenesis of drug allergy-current concepts and recent insights",
        "Mechanisms of drug-induced allergy",
        "Pathogenesis and diagnosis of delayed-type drug hypersensitivity reactions, from bedside to bench and back",
        "Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis",
        "Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment",
        "Clinical pharmacogenomics: Opportunities and challenges at point of care",
        "Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Causative drugs and clinical outcome in Stevens Johnson Syndrome (SJS), Toxic EpidermalNecrolysis (TEN), and SJS-TEN overlap in children",
        "HLA-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population",
        "Nevirapine induced Stevens-Johnson syndrome in an HIV infected patient",
        "Update on pathobiology in Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions",
        "Association between HLA-B alleles and carbamazepine-induced maculopapular exanthema and severe cutaneous reactions in Thai patients",
        "A success story in pharmacogenomics: Genetic ID card for SJS/TEN",
        "HLA-B? 58: 01 for allopurinol-induced cutaneous adverse drug reactions: Implication for clinical interpretation in Thailand",
        "Association between HLA-B?1502 allele and aromatic antiepileptic drugs-induced hypersensitivity syndrome reactions and the HLA-B? 15: 02 pharmacogenetics screening in autistic spectrum disorder",
        "Pharmacogenomics of drug-induced hypersensitivity reactions: Challenges, opportunities and clinical implementation",
        "The absence of CYP3A5?3 is a protective factor to anticonvulsants hypersensitivity reactions: A case-control study in Brazilian subjects",
        "Strong association between HLA-B?5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population",
        "Associations between HLA class i and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population",
        "Association between HLA-B?1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population",
        "Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B? 13: 01 allele in the Thai population",
        "Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin",
        "Cost minimization ofHLA-B?1502 screening before prescribing carbamazepine in Thailand",
        "A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients",
        "Independent strong association of HLA-A? 02: 06 and HLA-B?44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement",
        "Trans-ethnic study confirmed independent associations of HLA-A? 02: 06 and HLA-B?44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications",
        "Implementing pharmacogenomics in Europe: Design and implementation strategy of the Ubiquitous Pharmacogenomics Consortium",
        "Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin",
        "Association between HLA-B?1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland",
        "Ethical, social and legal issues in pharmacogenomics",
        "Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis",
        "Cost effectiveness of pharmacogenomics",
        "Association between carbamazepine-induced cutaneous adverse drug reactions and the HLAB?1502 allele among patients in central China",
        "Influence of genetic and non-genetic factors on phenytoin-induced severe cutaneous adverse drug reactions",
        "Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: An Asian series",
        "Strong association between HLA-B?1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis inmainlandHan Chinese patients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Al Ain",
            "@id": "60070823",
            "affilname": "College of Medicine and Health Sciences United Arab Emirates University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60070823",
            "affiliation-country": "United Arab Emirates"
        },
        {
            "affiliation-city": "Patra",
            "@id": "60069215",
            "affilname": "School of Health Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069215",
            "affiliation-country": "Greece"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Khun Poom Foundation",
        "Project of Her Royal Highness Princess Ubonratana Rajakanya Siriwatana Bhanawadee",
        "Thai Ministry of Science and Technology",
        "Thailand Center of Excellence for Life Sciences",
        "Mahidol University",
        "Thailand Research Fund",
        "National Research Council of Thailand"
    ]
}